Skip to main content
Clinical Trials/CTRI/2024/07/069936
CTRI/2024/07/069936RecruitingPhase 2

A Comparative Clinical Study to evaluate the efficacy of Shuddha Guggulu and Shuddha Salai guggulu in case of janugatasandhivata (w.s.r. to knee osteoarthritis)

State Ayurvedic College And Hospital Lucknow1 site in 1 country60 target enrollmentStarted: July 15, 2024Last updated:

Trial Snapshot

Phase
Phase 2
Status
Recruiting
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
vātapūrṇadṛtisparśa (Crepitus)

Study Overview

Brief Summary

Present study entitled “A comparative clinical study to evaluate the effectiveness of suddha guggulu and suddha salai guggulu in case of janugatasandhivata” (w.s.r. to Knee Osteo-arthritis)

AIMS AND OBJECTIVE

1.      To assess the efficacy of trial drugs in the management of janugata Sandhigata vata.

2.      To compare the efficacy of Guggulu and Salai guggulu in the management of janugata Sandhigat vata.

3.      To observe clinical improvement if any/prognosis/recurrence of symptoms during the follow up period.

4.      To assess the side effect of trial drugs if any.

PLAN OF STUDY

i) SELECTIONOF CASES :

·        For purpose of this clinical trials, patients of Janugat Sandhivata will be selected regardless of Sex, occupation and Socio-economic conditions with the age group of 41-70 years from the Kaya chikitsa O.P.D and I.P.D. of State Ayurvedic College and Hospital, Lucknow and the referred cases which fulfil criteria will also be included.

·        After a careful clinical history, examination and lab investigation as per proforma patient will be selected and screened for their suitability of getting enrolled in the clinical trial as per specific inclusion and exclusion criteria.

 ii) INCLUSION CRITERIA:

 Â·        Patient who give the consent to participate in study.

·        Patient of age group 41-70 years.

·        Patient fulfilling the diagnostic criteria as per clinical proforma.

·        The Patients who will be agree to stop all the previous medications of Osteoarthritis.

After diagnosis is established the patient will be included for clinical trial.

 CRITERIA FOR SELECTION OF CASES:

The diagnosis of Sandhivata patients enrolled in this study will be on the basis of clinical and radiological finding as follows: -

a) Clinical Findings:

The criteria for selection of cases is made on the basis of the cardinal sign and symptoms given in various Ayurvedic texts and in modern texts are kept in consideration, where the sign and symptoms of Sandhivata and O.A. are given as follows:-

Major Criteria

  1. वातपूर्णदृतिस्पर्श (Crepitus)

  2. सन्धिशूल (Pain in or around the knee joint)

  3. प्रसारणाकुन्चनयोप्रवृत्तिश्चसवेदना (Painful flexion and extension of knee joint)

  4. हन्तिसन्धि (Restricted range of movement of knee joints)

(Oedema)

 Minor Criteria

  1. Tenderness of knee joints

  2. Morning stiffness (< half an hour)

  3. सन्धि शोफ (Synovial effusion)

Increased walking time

 b) Radiological findings:

X-ray of the affected joints areas showing…..

Osteophytes (Bony swelling)

Reduced joint space

Subchondral bone sclerosis

Osteoporosis

Bone fragility

Patient having 3 or more than 3 major criteria and any 1 minor criteria along with at least 1 of above radiological finding will be register for the present clinical trial. We will also assist the sign and symptoms of sandhigatavata in comparison to ACR criteria for classification and reporting osteoarthritis of knee joints**.**

 ACR Revised criteria for early diagnosis of Knee Osteoarthritis 2016

Enty Criteria :

  • Knee pain and/or knee bony tenderness.

  • Absence of exclusion criteriab.

Domain I :

-         Mechanical Knee painc

-         Knee bony tenderness

-         Crepitus on Knee motion

-         Compatible synovial fluid

Domain II :

-         40< Age at onset < 50 years old

-         Age at onset > 50 years old

-         Knee bony enlargemente

-         Osteophytes in knee X-Ray or compatible knee MRI

a)     In the presence of 3 points outof 10 with at least 1 point from Domain II along with all entry criteria, the diagnosis of Knee OA can be established.

b)     Exclusion criteria are including:1) moderate to significant Knee synovitis 2) hot or red Knee 3) history and /or physical examination findings compatible with the internal derangement of knee.

c)     Knee pain that is initiated or increased with knee activity/ exercise and finished or decreased with knee resting.

d)     Clear fluid with normal viscosity accompanied by WBC count less than 2000/mm3 with less than 25% PMN.

e)     It must be ignored in the presence of osteophyte in the knee x-ray.

 f)      (Ref. Iraj Salehi-(2016), 2016 ACR Revised criteria for diagnosis of knee osteoarthritis, autoimmune dis ther approaches 3:118)

 INVESTIGATIONS

Few investigations will also be made for better assessment of disease severity and patients general condition as listed below –

A) Laboratory Investigation –

**Blood:**Routine: Hb%,CBC,B.Sugar (Fasting-PP)

**Specific:**E.S.R., R.A. factor, S. Uric acid, S. Calcium,

BMD Test, Vita D3, Thyroid profile (if required)

B) Radiological Investigation –

X- Ray Knee joints – AP/ Lateral view

MRI- knee joint (if required)

 iii) EXCLUSION CRITERIA:

Age below 41 years and above 70 years will be excluded.

Unwilling patient will be excluded.

Cases having severe joints deformities like Heberden node etc. will be excluded.

Cases with complications like severe ankylosed Joints and with infective joints disorders (Osteomyelitis), moderate to significant synovitis will also be excluded.

Pregnant women and Lactating mothers – will be excluded

Patient having Rheumatoid arthritis or having Gouty arthritis will be excluded.

Patient having secondary osteoarthritis (except control DM and thyroid disorder) infective or inflammatory arthritis of knee joint will be excluded.

 iv) CRITERIA FOR WITHDRAWAL:

Personal matter

Aggravation of complaints

Intercurrent illness

Any other difficulties

 v) TYPE OF STUDY: Phase 2 Randomised parallel design study.

**vi) PERIOD OF STUDY:**Three month

vii) FOLLOW UP PERIOD DURING TRIAL: Fifteen days intervals.

viii) FOLLOW UP PERIOD AFTER TRIAL: One month after treatment.

 ix) GROUPING OF PATIENTS: For the present clinical trial entitled “A comparative clinical study to evaluate the efficacy of Suddha Guggulu and Suddha Salai guggulu in case of janugata sandhivata (w.s.r. to knee osteoarthritis)” minimum 60 patients will selected of the age group 41-70years and divided in to two groups.

 Group- A: The patients of group A will be treated with Suddha Guggulu in the doses of 500 mg. TDS with lukewarm water after meal for three months. along with 15 ml nirgundi tail for local application twice a day in the form of gentle massage.

 Group-B: The patients of group B will be treated with Suddha Salai guggulu in the dose of 500 mg. TDS with lukewarm water after mealfor three months along with 15 ml. nirgundi tail for local application twice a day in the form of gentle massage.

 SAMPLE SIZE: Minimum 60 patients of Janugata sandhivata (Knee osteoarthritis) from O.P.D. and I.P.D. of State Ayurvedic College and Hospital, Lucknow and referred cases of other Hospitals will be taken for trial.

 TREATMENT SCHEDULE WITH DOSE AND DURATION:

The trial drugs will be given for a duration of three months as mentioned below ….

1. Suddha Guggulu :-

 Dose : One vati (500 mg each), TDS

Anupan : Luke warm water after meal

Duration : Three months

2. Suddha Salai guggulu :-

 Dose : One vati (500 mg each) , TDS

Anupan : Luke warm water after meal

Duration : Three months

   ASSESSMENT OF RESULTS :

For the gross assessment of result obtained, the response of the treatment will be determined in terms of degree of remission of sign and symptoms as :

·        Relieved : The patients having improvement ≥ 75% symptomatically and in radiological and laboratory findings (if any).

·        Improved : The patients having improvement < 75% and > 40% symptomatically, Radiological and laboratory findings (if any).

·        **Not Improved :**Patients having improvement < 40% symptomatically and in Radiological and laboratory findings (if any).

·        **Worsened Response :**Patients having deterioration in their symptoms, and in Radiological and laboratory finding (if any).

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
None

Eligibility Criteria

Ages
41.00 Year(s) to 70.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Patient who give the consent to participate in study.
  • Patient of age group 41-70 years.
  • Patient fulfilling the diagnostic criteria as per clinical proforma.
  • The Patients who will be agree to stop all the previous medications of Osteoarthritis.
  • After diagnosis is established the patient will be included for clinical trial.

Exclusion Criteria

  • Age below 41 years and above 70 years will be excluded.
  • Unwilling patient will be excluded.
  • Cases having severe joints deformities like Heberden node etc.
  • will be excluded.
  • Cases with complications like severe ankylosed Joints and with infective joints disorders (Osteomyelitis), moderate to significant synovitis will also be excluded.
  • Pregnant women and Lactating mothers – will be excluded
  • Patient having Rheumatoid arthritis or having Gouty arthritis will be excluded.
  • Patient having secondary osteoarthritis (except control DM and thyroid disorder) infective or inflammatory arthritis of knee joint will be excluded.

Outcomes

Primary Outcomes

vātapūrṇadṛtisparśa (Crepitus)

Time Frame: Before Trial, 15day, 30 day. 45 day, 60 day, 75 | day, 90 day, after trial

sandhiśūla (Pain in or around the knee joint)

Time Frame: Before Trial, 15day, 30 day. 45 day, 60 day, 75 | day, 90 day, after trial

prasāraṇākuncanayopravṛttiścasavedanā (Painful flexion and extension of knee joint)

Time Frame: Before Trial, 15day, 30 day. 45 day, 60 day, 75 | day, 90 day, after trial

hantisandhi (Restricted range of movement of knee joints)

Time Frame: Before Trial, 15day, 30 day. 45 day, 60 day, 75 | day, 90 day, after trial

sandhi śoth (Oedema)

Time Frame: Before Trial, 15day, 30 day. 45 day, 60 day, 75 | day, 90 day, after trial

Secondary Outcomes

  • X-ray of the affected joints areas showinG(1. Osteophytes (Bony swelling))
  • Tenderness of knee joints(Morning stiffness (Less than half an hour))
  • Hb%(CBC)

Investigators

Sponsor
State Ayurvedic College And Hospital Lucknow
Sponsor Class
Government medical college
Responsible Party
Principal Investigator
Principal Investigator

Mohd Waseem

State Ayurvedic College and Hospital Lucknow

Study Sites (1)

Loading locations...

Similar Trials